Additional Advances in Ulcerative Colitis Research and Clinical Trials With Benjamin Cohen, MD

The management of ulcerative colitis (UC) has undergone a fundamental transformation over the past two decades, driven by a deeper understanding of disease progression and an expanding armamentarium of advanced therapies. In this interview, Benjamin Cohen, MD, Co-Section Head and Clinical Director of Inflammatory Bowel Diseases in the Department of Gastroenterology, Hepatology, and Nutrition at the Cleveland Clinic, sat down to discuss how UC treatment paradigms have evolved, recent updates to management and treatment, and what clinicians should prioritize in contemporary practice.